Consult your healthcare provider for persistent headaches or severe symptoms, ensuring effective management strategies are in place
How quickly do providers respond to messages
Semaglutide Showing Promise in Treating Fatty Liver Disease A recent nationwide study finds that semaglutide improved liver enzyme levels in those suffering from nonalcoholic fatty liver disease (NAFLD) and other forms of the disease (NASH, or nonalcoholic steatohepatitis)
PlexusDx offers the Microdose GLP-1 Protocol at $129/month for patients wanting gentler introduction
Renal Outcomes Sixteen studies, including one meta-analysis, reported at least one renal outcome
The gutgenital tract microbiota interface and immune crosstalk is a recognised concept in womens health, and diabetes is associated with alterations in vaginal microbiota ecology, particularly around menopause transitions